Tilmicosin Premix with Best Quality Hot Sale

• Customization: Available
• Antibacterial Type: Natural Antibacterial
• Applied animal classification: Livestock, Poultry
• Certification: ISO
• Growth Promoting Type: Amino Acids, Broad-spectrum Antibiotics, Growth Hormone
• Shape: Powder
• Appearance: Powder
• Function: Bacteriostasis Growth Promoter
• Type: Premix
• Transport Package: Bag
• Specification: 7.5mt/20′fcl or 15mt/40′fcl
• Trademark: ND
• Origin: China

Product Description

Product Detail
Name:  Targeted tilmicosin liposomes premix
Feature:
Control immunosuppressive viral diseases (such as PCV, blue ear disease, etc.)
Control high fever, PRDC (porcine respiratory syndrome) infection and other diseases, reducing disease, reducing mortality

Assay	20%
Appearance	White powder

 

Tilmicosin 20% Premix  Indications

1. As an aid in reducing the severity of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae and Pasteurella multocida when fed to pigs approximately 7 days prior to an anticipated disease outbreak.
2. As an aid in reducing the severity of porcine polyserositis and arthritis associated with Haemophilus parasuis (Glasser's Disease) when fed to pigs approximately 7 days prior to an anticipated disease outbreak.
3. For the reduction of bovine respiratory disease (BRD) morbidity associated with Mannheimia haemolytica, Pasteurella multocida and/or Histophilus somni in groups of feedlot beef cattle experiencing an outbreak of BRD.
4. For the reduction in severity of respiratory disease caused by Pasteurella multocida in rabbits.

Note: To promote responsible use and limit the development of antimicrobial resistance, use Tilmicosin 20%  premix only under the following conditions:

1 In swine when factors associated with outbreaks of SRD or Glasser's Disease (such as herd health status, target pig population, herd management and environmental factors, etc.) have been carefully considered.
2 In feedlot beef cattle when:
a) clinical BRD has been diagnosed in at least 10% of animals in the group to be treated; AND
b) treatment is initiated within the first 45 days of arrival in the feedlot; AND
c) medication is limited to one single period of 14 consecutive days of treatment.